THURSDAY, SEPTEMBER 21, 2017

Researchers create heat-stable Ebola vaccine

According to a recent announcement, Soligenix Inc. -- a late-stage biopharmaceutical company that creates products for inflammation, biodefense and oncology, as well as other similar unmet medical needs -- has partnered with the University of Hawaii at Manoa and Hawaii Biotech to create an Ebola vaccine that is heat stable. Read More »

Hepatitis C viral variants cooperate to survive immune response

A recent study shows that the Hepatitis C virus (HCV) may use a wide range of tactics to decoy the immune system while the virus makes a separate attack, outmaneuvering the immune system’s response to the viral invaders. Read More »

Online technique predicts genetic resistance against TB drugs

Researchers at the London School of Hygiene & Tropical Medicine recently developed an online tool that can predict which drugs are best for each tuberculosis (TB) patient. Read More »

New study reveals complex emerging zoonotic malaria

A new study, recently published in PLOS Pathogens, revealed many of the complexities behind the new emerging zoonotic malaria. Read More »

North Dakota to begin West Nile virus surveillance on June 1

The North Dakota Department of Health has partnered with several federal, state, local and private agencies to begin surveillance for West Nile virus, starting June 1, 2015. Read More »

Faster test detects rifampicin resistance to TB

A large-scale study recently published in PLoS One suggests that using Xpert MTB/RIF as the first test to detect tuberculosis (TB) in India’s public health facilities may notably improve the number of cases diagnosed. Read More »

Probable case of bird flu found in Iowa

According to a recent announcement, the Iowa Department of Agriculture and Land Stewardship has responded to a potential highly pathogenic avian influenza (HPAI) case in Iowa’s Hamilton County. Read More »

Researchers exploit HIV's "sweet tooth" to weaken virus

Researchers recently discovered that HIV has a "sweet tooth" for sugar and nutrients from activated immune cells, which may prove to be the cell’s weak spot where scientists can administer treatments for patients. Read More »

Invetech, Vaxxas awarded 2015 Good Design Award for needle-free technology

Invetech, a leading company focusing on custom automation, instrument development and contact manufacturing, and Vaxxas, a biotechnology start-up best known for developing the needle-free drug delivery technology known as Nanopatch, recently won the 2015 Good Design Award for creating the Nanopatch Jet Coating Instrument. Read More »